No Picture
Uncategorized

Sr. Market Development Manager, Genetic Analysis Solutions – Thermo Fisher Scientific – San Diego, CA

A degree in Marketing, Communications or Business, with previous work experience in biotechnology, medical devices, or pharmaceutical industry is also…From Thermo Fisher Scientific – Wed, 01 Dec 2021 06:18:11 GMT – View all San Diego, […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Uncategorized

Research Associate – CAR-T(DAR-T) In Vivo Pharmacology – Sorrento Therapeutics – San Diego, CA

Sorrento Therapeutics (“Sorrento”) is currently looking for a experienced Research Associate. The candidate will participate in pre-clinical in-vivo and in…From Sorrento Therapeutics – Wed, 01 Dec 2021 03:31:26 GMT – View all San Diego, CA […]

No Picture
Uncategorized

Scientist/Process Development & Manufacturing Associate II – Sorrento Therapeutics – San Diego, CA

Sorrento Therapeutics (“Sorrento”) is seeking an experienced Scientist/Process Development and Manufacturing Associate who will be responsible for process…From Sorrento Therapeutics – Wed, 01 Dec 2021 03:31:26 GMT – View all San Diego, CA jobsClick here […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Ensysce Biosciences Announces Clinical Trial Progress of its New Class of Opioids

SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with novel technologies that may provide new hope for those in severe pain, today announced the completion of a positive safety review and enrollment of the… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Regulus Therapeutics Announces Closing of $34.6 Million Private Placement of Equity

SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced the closing of its previously announced private placement of equity. The Company received gross proceeds of… Click here to view original post… […]

No Picture
News

MEI Pharma Announces Proposed Public Offering of Common Stock

SAN DIEGO–(BUSINESS WIRE)–MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced today that it plans to offer 17,500,000 shares of its common stock in an underwritten public offering. In connection with the offering, the Company intends to grant the underwriters a 30-day… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Flu Virus Shells Could Improve Delivery of mRNA Into Cells

UC San Diego nanoengineers developed a new and potentially more effective way to deliver messenger RNA (mRNA) into cells. Their approach involves packing mRNA inside nanoparticles that mimic the flu virus—a naturally efficient vehicle for delivering genetic material such as RNA inside cells. Click here to view original post… […]

No Picture
News

BioCina officially opens full-service CDMO in Adelaide, Australia, including mRNA and pDNA cGMP manufacturing

SAN DIEGO and ADELAIDE, Australia: SAN DIEGO and ADELAIDE, Australia, Nov. 30, 2021 /PRNewswire/ — BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the official opening of its new biologics manufacturing facility in Adelaide, Australia…. Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Which side is which?: How the brain perceives borders

LA JOLLA—In the classic “Rubin’s vase” optical illusion, you can see either an elaborate, curvy vase or two faces, noses nearly touching. At any given moment, which scene you perceive depends on whether your brain is viewing the central vase shape to be the foreground or background of the picture…. Click here to view original post… […]

No Picture
News

New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing

CARLSBAD, Calif.: CARLSBAD, Calif., Nov. 30, 2021 /PRNewswire/ — For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen TrueCut HiFi Cas9 Protein* significantly minimizes off-target events while retaining maximum on-target editing efficiency. Thermo Fisher Scientific introduced the… Click here to view original post… […]

No Picture
News

Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma

SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the VAL-083 treatment arm in the Global Coalition for Adaptive Research (GCAR) registrational Phase 2/3 clinical… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Evofem Biosciences Announces Successful Type C Meeting with FDA for STI Prevention Product Candidate

SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) today reported a successful Type C meeting with the U.S. Food and Drug Administration in which agreement was reached on the preliminary submission strategy for EVO100 for two investigational indications: the prevention of urogenital chlamydia in… Click here to view original post… […]

No Picture
News

Lineage Reports Fourth Case of Retinal Tissue Restoration With OpRegen®

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that restoration of retinal tissue was observed in a fourth patient enrolled in the Company’s Phase 1/2a clinical study of its lead product… Click here to view original post… […]

No Picture
News

ViaCyte Appoints Marty Lorenzo as General Counsel

SAN DIEGO: SAN DIEGO, Nov. 30, 2021 /PRNewswire/ — ViaCyte, Inc., a clinical-stage regenerative medicine company developing novel cell replacement therapies to address diseases with significant unmet needs, today announced the appointment of Marty Lorenzo as General Counsel. Mr. Lorenzo brings over 20 years in the legal profession leading corporate… Click here to view original post… […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

After Big Pharma sparked interest in the US, Ablaze looks to bring radiopharmaceuticals overseas

Thanks in part to interest from Big Pharma players like Bayer and Novartis over the last decade, there’s been no shortage in cash for new companies looking to slay tumor cells with targeted radioisotopes. Now a transpacific upstart has hooked $75 million to bring the increasingly popular drugs to China…. Click here to view original post… […]

No Picture
News

ABM Therapeutics Receives IND Approval in China for BRAF Inhibitor ABM-1310

SAN DIEGO and SHANGHAI: SAN DIEGO and SHANGHAI, Nov. 30, 2021 /PRNewswire/ — ABM Therapeutics (ABM), a clinical-stage biopharmaceutical company with a focus on treating brain cancers and cancer metastases, today announced that its IND application for ABM-1310, a new-generation BRAF inhibitor, has been approved by the National Medical Products… Click here to view original post… […]

No Picture
Uncategorized

Lab Aide 2 – Illumina – San Diego, CA

1+ years of industry experience in a biotechnology environment. We are seeking a motivated and self-directed individual to support a variety of lab support…From Illumina – Tue, 30 Nov 2021 06:11:30 GMT – View all […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System

SAN DIEGO, Nov. 29, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the commercial launch of its BioXp™ mRNA synthesis kits with CleanCap® Reagent AG, a proprietary mRNA capping technology from TriLink BioTechnologies, part of Maravai LifeSciences (NASDAQ: MRVI)…. Click here to view original post… […]

No Picture
News

Sorrento Publishes an Abivertinib Teaser Entitled “Abivertinib – A Franchise Oral Therapeutic for Cancer, COVID-19 and Autoimmune Diseases”

SAN DIEGO, Nov. 29, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced the publication of a Teaser titled “Abivertinib – a Franchise Oral Therapeutic for Cancer, COVID-19 and Autoimmune Diseases” (“Abivertinib Teaser”). Sorrento intends to use the Abivertinib Teaser to engage in discussions with interested third… Click here to view original post… […]